EHA2024レポート⑥ Late-breaking Session

経口ビタミンCが低リスク骨髄系腫瘍のOSを延長
TET2の補因子として役割を果たす Vitamin C Supplementation Shows Promising Results in Early-Stage Myeloid Malignancies and Precursor Conditions: Findings from the Randomized Controlled Phase 2 EVl-2 Clinical Study (#LB3444)

Stine Ulrik Mikkelsen（Rigshospitalet,Biotech Research and Innovation Centre, University of Copenhagen, Denmark）